1. Department of Diabetes Complications Research, Novo Nordisk A/S, Måløv, Denmark;
2. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark;
3. Department of Incretin & Obesity Pharmacology, Novo Nordisk A/S, Måløv, Denmark;
4. Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands, Leiden University Medical Center, Leiden, The Netherlands;
5. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands